A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored f… (NCT07490860) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
United States45 participantsStarted 2026-07-01
Plain-language summary
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (within 15 years) who are aged 50-80 with at least a 20 pack-year smoking history. LCS lowers lung cancer death by 20%; however, data shows that LCS completion remains low among minority groups in the United States. The restorative justice-based LCS decision-making support intervention in this trial has been specifically tailored to meet the needs of Black individuals. It is designed to reduce racial unfairness by promoting trust, shared understanding, and empowerment in clinical decision making while addressing the social and historical circumstances of health inequalities. This may be an effective way to increase LCS among Black community members.
Who can participate
Age range
50 Years – 77 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Identify as Black or African American
* Between ages 50-77
* Self-reported 20-pack year smoking history
* Ongoing commercial tobacco use within the past 15 years
* Proficiency in the English language
Exclusion Criteria:
* Has a documented chest CT within the past one year
* Personal history of lung cancer or symptoms associated with lung cancer
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is specifically designed for Black individuals and uses something called a 'restorative justice' approach to help with lung cancer screening decisions — can you explain what that framing means in practice and whether you think it might be a good fit for me?
2Since this trial is listed as 'not yet recruiting,' do you know when it's expected to open, and is there anything I should be doing in the meantime to stay on track with lung cancer screening?
3The trial is measuring whether the intervention is acceptable to participants and whether it improves knowledge about lung cancer screening — so it's not testing a new treatment, right, and does that mean my actual screening plan would still follow standard guidelines?
4Given that this is a decision-support study rather than a drug or procedure trial, what would my involvement actually look like day-to-day, and how much time would it require?
5If I don't end up joining this trial, what does the current standard recommendation look like for lung cancer screening given my personal risk factors, and would you recommend I pursue that now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intervention acceptability
Timeframe: At post-intervention (Day 1)
2
Lung cancer screening knowledge
Timeframe: At pre- and post-intervention (both on Day 1)